Form 8-K - Current report:
SEC Accession No. 0001104659-25-020023
Filing Date
2025-03-04
Accepted
2025-03-04 08:01:48
Documents
55
Period of Report
2025-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258153d1_8k.htm   iXBRL 8-K 34753
2 EXHIBIT 99.1 tm258153d1_ex99-1.htm EX-99.1 61573
6 GRAPHIC tm258153d1_ex99-1img001.jpg GRAPHIC 507635
7 GRAPHIC tm258153d1_ex99-1img002.jpg GRAPHIC 1179247
8 GRAPHIC tm258153d1_ex99-1img003.jpg GRAPHIC 664091
9 GRAPHIC tm258153d1_ex99-1img004.jpg GRAPHIC 474251
10 GRAPHIC tm258153d1_ex99-1img005.jpg GRAPHIC 354938
11 GRAPHIC tm258153d1_ex99-1img006.jpg GRAPHIC 704661
12 GRAPHIC tm258153d1_ex99-1img007.jpg GRAPHIC 741115
13 GRAPHIC tm258153d1_ex99-1img008.jpg GRAPHIC 741182
14 GRAPHIC tm258153d1_ex99-1img009.jpg GRAPHIC 603494
15 GRAPHIC tm258153d1_ex99-1img010.jpg GRAPHIC 595491
16 GRAPHIC tm258153d1_ex99-1img011.jpg GRAPHIC 508215
17 GRAPHIC tm258153d1_ex99-1img012.jpg GRAPHIC 596513
18 GRAPHIC tm258153d1_ex99-1img013.jpg GRAPHIC 326227
19 GRAPHIC tm258153d1_ex99-1img014.jpg GRAPHIC 687793
20 GRAPHIC tm258153d1_ex99-1img015.jpg GRAPHIC 712087
21 GRAPHIC tm258153d1_ex99-1img016.jpg GRAPHIC 784874
22 GRAPHIC tm258153d1_ex99-1img017.jpg GRAPHIC 538627
23 GRAPHIC tm258153d1_ex99-1img018.jpg GRAPHIC 468007
24 GRAPHIC tm258153d1_ex99-1img019.jpg GRAPHIC 774919
25 GRAPHIC tm258153d1_ex99-1img020.jpg GRAPHIC 726603
26 GRAPHIC tm258153d1_ex99-1img021.jpg GRAPHIC 675879
27 GRAPHIC tm258153d1_ex99-1img022.jpg GRAPHIC 630718
28 GRAPHIC tm258153d1_ex99-1img023.jpg GRAPHIC 707153
29 GRAPHIC tm258153d1_ex99-1img024.jpg GRAPHIC 710877
30 GRAPHIC tm258153d1_ex99-1img025.jpg GRAPHIC 671262
31 GRAPHIC tm258153d1_ex99-1img026.jpg GRAPHIC 634589
32 GRAPHIC tm258153d1_ex99-1img027.jpg GRAPHIC 420410
33 GRAPHIC tm258153d1_ex99-1img028.jpg GRAPHIC 534658
34 GRAPHIC tm258153d1_ex99-1img029.jpg GRAPHIC 687508
35 GRAPHIC tm258153d1_ex99-1img030.jpg GRAPHIC 508280
36 GRAPHIC tm258153d1_ex99-1img031.jpg GRAPHIC 1003405
37 GRAPHIC tm258153d1_ex99-1img032.jpg GRAPHIC 455411
38 GRAPHIC tm258153d1_ex99-1img033.jpg GRAPHIC 540838
39 GRAPHIC tm258153d1_ex99-1img034.jpg GRAPHIC 892618
40 GRAPHIC tm258153d1_ex99-1img035.jpg GRAPHIC 576716
41 GRAPHIC tm258153d1_ex99-1img036.jpg GRAPHIC 673576
42 GRAPHIC tm258153d1_ex99-1img037.jpg GRAPHIC 841220
43 GRAPHIC tm258153d1_ex99-1img038.jpg GRAPHIC 805208
44 GRAPHIC tm258153d1_ex99-1img039.jpg GRAPHIC 290930
45 GRAPHIC tm258153d1_ex99-1img040.jpg GRAPHIC 668593
46 GRAPHIC tm258153d1_ex99-1img041.jpg GRAPHIC 317858
  Complete submission text file 0001104659-25-020023.txt   36020912

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20250304.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20250304_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20250304_pre.xml EX-101.PRE 22357
57 EXTRACTED XBRL INSTANCE DOCUMENT tm258153d1_8k_htm.xml XML 3558
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 25701607
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)